T HE A DRENERGIC R ECEPTORS
T H E R E C E P T O R S
K IM A. N EVE , S ERIES E DITOR
The Adrenergic Receptors: In the 21st Century,
EDITED BYDianne M. Perez, 2005
The Melanocortin Receptors,
EDITED BYRoger D. Cone, 2000 The GABA Receptors, Second Edition,
EDITED BYS. J. Enna
and Norman G. Bowery, 1997
The Ionotropic Glutamate Receptors,
EDITED BYDaniel T.
Monaghan and Robert Wenthold, 1997
The Dopamine Receptors,
EDITED BYKim A. Neve and Rachael L. Neve, 1997
The Metabotropic Glutamate Receptors,
EDITED BYP. Jeffrey Conn and Jitendra Patel, 1994
The Tachykinin Receptors,
EDITED BYStephen H. Buck, 1994 The Beta-Adrenergic Receptors,
EDITED BY
John P. Perkins, 1991
Adenosine and Adenosine Receptors,
EDITED BYMichael Williams, 1990
The Muscarinic Receptors,
EDITED BYJoan Heller Brown, 1989 The Serotonin Receptors,
EDITED BYElaine Sanders-Bush, 1988 The Alpha-2 Adrenergic Receptors,
EDITED BYLee Limbird,
1988
The Opiate Receptors,
EDITED BYGavril W. Pasternak, 1988 The Alpha-1 Adrenergic Receptors,
EDITED BYRobert R.
Ruffolo, Jr., 1987
The GABA Receptors,
EDITED BYS. J. Enna, 1983
The Adrenergic Receptors
In the 21 ST Century
Edited by
Dianne M. Perez
Department of Molecular Cardiology The Lerner Research Institute,
The Cleveland Clinic Foundation, Cleveland, OH
© 2006 Humana Press Inc.
999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 www.humanapress.com All rights reserved.
No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. All articles, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher.
Cover design by Patricia F. Cleary
Cover illustration: Fluorescent ligand (QAPB, also known as BODIPY FL-prazosin, 30 nM) binding to α1-adrenoceptors in isolated smooth muscle cells. The data is displayed as an iso- surface model in which the cell membrane is rendered with a transparent “blue” surface.
Intracellular fluorescent regions, indicating ligand-receptor binding, are colored orange and green in the two cells. Bright “clusters” of fluorescence are shown as red in both cells. Alternative views and explanations of the data are given in Chapter 6 by McGrath and Daly.
This publication is printed on acid-free paper. ∞
ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials
For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel.: 973-256- 1699; Fax: 973-256-8341; E-mail: orders@humanapr.com; or visit our Website: www.
humanapress.com.
Photocopy Authorization Policy:
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $30.00 per copy is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923.
For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [1-58829-423-4/06 $30.00].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1 eISBN 1-59259-931-1
Library of Congress Cataloging-in-Publication Data
The adrenergic receptors : in the 21st century / edited by Dianne M. Perez.
p. cm. -- (The receptors)
Includes bibliographical references and index.
ISBN 1-58829-423-4 (alk. paper)
1. Adrenaline--Receptors. 2. Pharmacogenetics. I. Perez, Dianne M. II.Series.
QP364.7.A375 2005 612.4'5--dc22
2005008529
Preface
Our understanding of adrenergic function has advanced considerably in the 15 years since three adrenergic receptor books were published in The Receptors series. In the late 1980s, many of the adrenergic subtypes had not yet been cloned.
Most of the studies during that time focused on traditional pharmacological approaches in selected tissues and cell lines. We learned about structure–function relationships through the manipulation of the drug, not the receptor. We understood that there were multiple subtypes within each class of adrenergic receptors, but the functions of the subtypes were unclear because they seemed to control the same signal transduction and biological processes. Molecular cloning of the receptors led to the realization that there were many different subtypes, some not previously described by the tissue pharmacology. With the genes of these receptors in hand, the field has now advanced with more precise experiments and questions, but it has still suffered from the lack of highly selective ligands and antibodies. Foreseeing that these limitations would not be overcome any time in the near future, scientists in the adrenergic receptor field—using modern genetic approaches—started to redirect their work to answer questions about structure and function and the possible physiological and patho- physiological pathways that would be regulated by adrenergic receptors. The Adrenergic Receptors: In the 21st Century focuses on these modern approaches and was written by the scientists who developed them to elucidate adrenergic receptor function.
Dianne M. Perez
v
Contents
vii
Preface ... v Contributors ... ix Color Plates ... xi
P
ARTI: H
ISTORICALP
ERSPECTIVES1 Adrenergic Receptors: Historical Perspectives From the 20th Century
David B. Bylund ... 3 P
ARTII: S
TRUCTURE–F
UNCTION2 Ligand Binding, Activation, and Agonist Trafficking Angela M. Finch, Valerie Sarramegna,
and Robert M. Graham ... 25 3 New Signal Transduction Paradigms
Kenneth P. Minneman ... 87 4 Regulation of the Cellular Localization and Trafficking
of the Adrenergic Receptors
Michael T. Piascik, Mary Lolis García-Cazarin,
and Steven R. Post ... 107 5 Adrenergic Receptors in Clinical Medicine
Martin C. Michel and Paul A. Insel ... 129 P
ARTIII: I
MAGINGA
DRENERGICR
ECEPTORS ANDT
HEIRF
UNCTION6 Use of Fluorescent Ligands and Receptors to Visualize Adrenergic Receptors
John C. McGrath and Craig J. Daly ... 151 7 Localization of Adrenergic Receptor Subtypes and
Transgenic Expression of Fluorescent-Tagged Receptors
Dianne M. Perez ... 173
P
ARTIV: G
ENETICALLYA
LTEREDM
OUSEM
ODELS8 The α
1-Adrenergic Receptors:
Lessons From Knockouts
Paul C. Simpson ... 207 9 The α
2-Adrenergic Receptors:
Lessons From Knockouts
Christopher M. Tan and Lee E. Limbird ... 241 10 The β-Adrenergic Receptors:
Lessons From Knockouts
Yang Xiang and Brian Kobilka ... 267 11 Lessons From Overexpressed Mouse Models
Cinzia Perrino, Liza Barki-Harrington,
and Howard A. Rockman ... 293 12 Adrenergic Receptor Signaling Components
in Gene Therapy
Andrea D. Eckhart and Walter J. Koch ... 321 P
ARTV: P
HARMACOGENOMICS13 Genetic, Molecular, and Clinical Characterization of Adrenergic Receptor Polymorphisms
Stephen B. Liggett ... 339 14 Microarray Analysis of Novel Adrenergic
Receptor Functions
Boyd Rorabaugh, June Yun, and Dianne M. Perez ... 365 P
ARTVI: S
UMMARY ANDF
UTUREE
NDEAVORS15 Summary and Future Endeavors
Dianne M. Perez ... 395 Index ... 397
viii Contents
Contributors
ix
L
IZAB
ARKI-H
ARRINGTON• Division of Cardiology, Duke University Medical Center, Durham, NC
D
AVIDB. B
YLUND• Department of Pharmacology, University of Nebraska Medical Center, University of Nebraska, Omaha, NE
C
RAIGJ. D
ALY• Autonomic Physiology Unit, Institute of Biomedical and Life Sciences, Division of Neuroscience and Biomedical Systems,
University of Glasgow, Glasgow, Scotland, UK
A
NDREAD. E
CKHART• Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA
A
NGELAM. F
INCH• Molecular Cardiology Program, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
M
ARYL
OLISG
ARCÍA-C
AZARIN• Department of Molecular and Biomedical Pharmacology, The University of Kentucky College of Medicine, Lexington, KY
R
OBERTM. G
RAHAM• Molecular Cardiology Program, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
P
AULA. I
NSEL• Department of Pharmacology and Medicine, University of California San Diego, San Diego, CA
B
RIANK
OBILKA• Department of Molecular and Cellular Physiology, Stanford Medical Center, Stanford University, Palo Alto, CA
W
ALTERJ. K
OCH• Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA
S
TEPHENB. L
IGGETT• Cardiopulmonary Research Center, University of Cincinnati College of Medicine, Cincinnati, OH
L
EEE. L
IMBIRD• Department of Pharmacology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN
J
OHNC. M
CG
RATH• Autonomic Physiology Unit, Institute of Biomedical and Life Sciences, Division of Neuroscience and Biomedical Systems, University of Glasgow, Glasgow, Scotland, UK
M
ARTINC. M
ICHEL• Department of Pharmacology, University of Amsterdam, Amsterdam, The Netherlands
K
ENNETHP. M
INNEMAN• Department of Pharmacology, Emory University,
Atlanta, GA
x Contributors
D
IANNEM. P
EREZ• Department of Molecular Cardiology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH C
INZIAP
ERRINO• Division of Cardiology, Duke University Medical Center,
Durham, NC
M
ICHAELT. P
IASCIK• Department of Molecular and Biomedical Pharmacology, The University of Kentucky College of Medicine, Lexington, KY
S
TEVENR. P
OST• The Department of Molecular and Biomedical Pharmacology, The University of Kentucky College of Medicine, Lexington, KY
H
OWARDA. R
OCKMAN• Division of Cardiology, Duke University Medical Center, Durham, NC
B
OYDR
ORABAUGH• Department of Pharmacology, College of Pharmacy, Ohio Northern University, Ada, OH
V
ALERIES
ARRAMEGNA• Molecular Cardiology Program, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia P
AULC. S
IMPSON• Cardiology Division, San Francisco VA Medical Center,
and the CVRI and Department of Medicine, University of California, San Francisco, CA
C
HRISTOPHERM. T
AN• Department of Pharmacology, Merck Research Laboratories, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada
Y
ANGX
IANG• Department of Molecular and Cellular Physiology, Stanford Medical Center, Stanford University, Palo Alto, CA
J
UNEY
UN• The Department of Physiology and Pharmacology, Northeastern
Ohio Universities College of Medicine, Rootstown, OH
Color Plates
Color Plates follow p. 148.
Color Plate 1. Confocal imaging of human aortic smooth muscle cells trans- fected with an adenovirus (Fig. 1, Chapter 4; see full caption and discussion on pp. 117–118).
Color Plate 2. Classical AR signaling (Fig. 1, Chapter 11; see full caption and discussion on p. 294).
Color Plate 3. Major mechanisms involved in β-AR desensitization and intern- alization (Fig. 2, Chapter 11; see full caption on p. 296 and discussion on p. 295).
Color Plate 4. Histopathological characteristics of left ventricular specimens taken from mice overexpressing the human β
1-AR (Fig. 5, Chapter 11; see full caption on p. 307 and discussion on pp. 306–308).
Color Plate 5. Phylogenetics of β
2-AR haplotypes (Fig. 2, Chapter 13; see full caption on p. 342 and discussion on pp. 340–341).
xi